| # | Drug | Count |
|---|---|---|
| 0 | GEMCITABINE HYDROCHLORIDE | 23 |
| 1 | GEMCITABINE | 19 |
| 2 | OXALIPLATIN | 14 |
| 3 | CYCLOPHOSPHAMIDE | 6 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 6 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 6 |
| 6 | DACARBAZINE | 5 |
| 7 | DOXORUBICIN | 5 |
| 8 | INDIUM IN -111 PENTETREOTIDE | 5 |
| 9 | TEMOZOLOMIDE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INDIUM IN -111 PENTETREOTIDE | 5 | 0.0391 |
| 1 | ACYCLOVIR SODIUM | 1 | 0.0008 |
| 2 | FOSPHENYTOIN SODIUM | 2 | 0.0008 |
| 3 | DOBUTAMINE HYDROCHLORIDE | 1 | 0.0008 |
| 4 | DACARBAZINE | 5 | 0.0007 |
| 5 | GRANULOCYTE COLONY STIMULATING FACTOR | 1 | 0.0005 |
| 6 | GEMCITABINE HYDROCHLORIDE | 23 | 0.0004 |
| 7 | TOPOTECAN HYDROCHLORIDE | 1 | 0.0004 |
| 8 | LOMUSTINE | 1 | 0.0004 |
| 9 | TEMOZOLOMIDE | 5 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 18 |
| 1 | Alkylating Drug [EPC] | 16 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 6 |
| 3 | Microtubule Inhibitor [EPC] | 5 |
| 4 | Proton Pump Inhibitor [EPC] | 5 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 4 |
| 6 | Corticosteroid [EPC] | 4 |
| 7 | Proteasome Inhibitor [EPC] | 4 |
| 8 | Anti-epileptic Agent [EPC] | 3 |
| 9 | Kinase Inhibitor [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nuclear Export Inhibitor [EPC] | 1 | 0.0001 |
| 1 | Radioligand Therapeutic Agent [EPC] | 1 | 0.0001 |
| 2 | Oxazolidinone Antibacterial [EPC] | 2 | 0.0001 |
| 3 | Platinum-based Drug [EPC] | 18 | 0.0001 |
| 4 | Alkylating Drug [EPC] | 16 | 0.0001 |
| 5 | Protease Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Proteasome Inhibitor [EPC] | 4 | 0.0000 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Microtubule Inhibitor [EPC] | 5 | 0.0000 |
| 9 | Thiazide-like Diuretic [EPC] | 1 | 0.0000 |